MenaQ7® vitamin K2

Menaquinone-7 (MK-7), the form of Vitamin K2, stands as the most easily absorbable, enduring, and biologically active variant of Vitamin K. Among Vitamin K sources, MenaQ7® alone falls within the recommended daily intake levels, demonstrating both safety and effectiveness at a mere 45 mcg per day. Furthermore, MenaQ7® is the singular Vitamin K2 type substantiated by clinical trials for enhancing bone and cardiovascular health. Supported by an extensive collection of 22+ clinical studies attesting to its secure and beneficial effects, MenaQ7®'s robust scientific foundation assures the fulfillment of its promised advantages.

Cardiovascular health*

An adequate intake of Vitamin K2 has been shown to positively influence the cardiovascular system.*

Bone health*

Bone loss occurs naturally as we age, but with sufficient Vitamin K2 intakes, particularly starting at an early age, this loss can indeed be slowed.**

Children’s health*

Vitamin K-insufficient diets put children at risk of not optimiz­ing their ability to grow strong bones and, potentially, a well-functioning cardiovas­cular system later in life.***

MK-7 form of vitamin K2

Although all K vitamins share a structural likeness, their distinction lies in the length of the "side chain." A lengthier side chain corresponds to heightened effectiveness and efficiency. As a result, long-chain menaquinones, particularly MK-7, emerge as the most advantageous.

These variants are characterized by near-complete absorption, allowing for lower dosage requirements and an extended presence in the bloodstream. This prolonged presence allows Vitamin K2, specifically MK-7, to be accessible to tissues beyond the liver, notably bones, arteries, and soft tissues.

Evidently, multiple studies consistently underscore the superior effectiveness of Vitamin K2 as MK-7 in comparison to MK-4.

*MenaQ7® and Cardiovascular Health

¹ Vermeer C and Vik H. Vascular Diseases and Therapeutics. 2020

² Mansour et al. Journal of the American Society of Hypertension. 2017

³ Aoun et al. BMC Nephrology. 2017

⁴ Knapen et al. European Journal of Clinical Nutrition. 2016

⁵ Knapen et al. Journal of Nutritional Science. 2015

**MenaQ7® and Bone Health

¹ Knapen et al. Osteoporosis International. 2013

² Ozdemir et al. Journal Pediatric Hematology Oncology. 2013

³ van Summeren et al. British Journal of Nutrition. 2009

***MenaQ7® in Healthy Populations and Children’s Health

¹ Theuwissen et al. Food & Function. 2014

² van Summeren et al. British Journal of Nutrition. 2009